Close X
Tuesday, December 3, 2024
ADVT 
International

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report

Darpan News Desk IANS, 02 May, 2022 11:25 AM
  • Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report

New York, May 2 (IANS) Omicron's latest subvariant BA.2.12.1, responsible for about one-fourth of Covid-19 cases in the US, shows that the virus is not showing any signs of decline even over two years after it was first detected in humans.

BA.2.12.1 has also been detected in Australia and New Zealand.

Preliminary research suggests it is about 25 per cent more transmissible than the BA.2 subvariant that is currently dominant nationally, according to the Centers for Disease Control and Prevention.

According to virologists, although the SARS-CoV-2 virus has repeatedly changed its structure and chemistry, it still has abundant evolutionary space to explore, Washington Post reported.

While existing vaccination can still reduce the risk of severe Covid disease, the variants can evade many of the neutralising antibodies that are the immune system's front line of defence.

"It's evolving at a fairly rapid rate. I do think we need to aggressively consider whether we should update vaccines, and do it soon," Jesse Bloom, a computational biologist at the Fred Hutchinson Cancer Research Center in Seattle was quoted as saying.

"The evolution is much more rapid and expansive than we initially estimated," added Michael Osterholm, infectious-disease expert at the University of Minnesota.

"Every day I wake up, I fear there will be a new subvariant that we will have to consider. . . We're seeing sub-variants of sub-variants," he added.

Other mutations include BA.4 and BA.5, recently identified by scientists in South Africa. It has led to a fresh wave of Covid in the country.

Besides South Africa, the sub variants have also been detected in more than 20 countries including Australia, Austria, Belgium, China, Israel, Denmark, France, Germany, Pakistan, UK, US and Switzerland.

Apart from mutation, the virus has another trick up its sleeve: recombination. It happens when two distinct strains infect a single host simultaneously and their genes become entangled, the Post reported.

The recombination process is the origin of what's known as Omicron XE. That recombinant probably emerged from a person co-infected with the original Omicron variant and the BA.2 subvariant.

It was always possible in theory, but the identification of actual recombinants provides "proof of concept," Jeremy Luban, a virologist at the University of Massachusetts Medical School was quoted as saying.

The worst-case scenario would be the emergence of a variant or recombinant that renders current vaccines largely ineffective at blocking severe disease. But so far, that hasn't happened. And no "recombinant" has spread like Omicron or other recent variants and sub-variants, the report said.

MORE International ARTICLES

Serving Humanity At No Cost

Serving Humanity At No Cost
The purpose of this hospital is to serve humanity; Sikhs are known for this, we are doing this for years. Soon you will see, this will not be just India’s but the world’s largest kidney dialysis hospital.

Serving Humanity At No Cost

Prince Philip, Duke of Edinburgh, dead at 99

Prince Philip, Duke of Edinburgh, dead at 99
"It is with deep sorrow that Her Majesty The Queen has announced the death of her beloved husband, His Royal Highness The Prince Philip, Duke of Edinburgh," The Royal Family said on Twitter.

Prince Philip, Duke of Edinburgh, dead at 99

UK advises limiting AstraZeneca in under-30s amid clot worry

UK advises limiting AstraZeneca in under-30s amid clot worry
While the benefits of the vaccine still outweigh the risks, that assessment is “more finely balanced" among younger people who are less likely to become seriously ill with COVID-19

UK advises limiting AstraZeneca in under-30s amid clot worry

COVID vaccine found highly effective in real-world US study

COVID vaccine found highly effective in real-world US study
The two vaccines available since December — Pfizer and Moderna — were 90% effective after two doses, the Centers for Disease Control and Prevention reported Monday. In testing, the vaccines were about 95% effective in preventing COVID-19.

COVID vaccine found highly effective in real-world US study

Reputation of AstraZeneca's COVID vaccine marred by missteps

Reputation of AstraZeneca's COVID vaccine marred by missteps
In Norway, a top official warned on Monday it might not be able to resume its use of the vaccine because so many people were rejecting it.

Reputation of AstraZeneca's COVID vaccine marred by missteps

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Will you need a 'vaccine passport' to travel?
It is not clear, however, whether any of the passports under development will be accepted broadly around the world, and the result could be confusion among travellers and disappointment for the travel industry.

EXPLAINER: Will you need a 'vaccine passport' to travel?